W Kimryn Rathmell

26PUBLICATIONS

179CO-AUTHORS

Predictive and prognostic markersMetabolic medicineBiologically active moleculesInnate immunityMolecular targets

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (26)

Sort by Publication Date:

|Jun 17, 2026

Mitochondrial potential reflects T cell fitness and function during cancer immunotherapy.

|Nov 20, 2025

Targeted Metabolomic Methods for <sup>13</sup>C Stable Isotope Labeling with Uniformly Labeled Glucose and Glutamine Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).

Erin Q Jennings, W Kimryn Rathmell, Jeffrey C Rathmell

|Jun 11, 2025

Potentiating cancer immunotherapies with modular albumin-hitchhiking nanobody-STING agonist conjugates.

Blaise R Kimmel, Karan Arora, Neil C Chada

|Sep 20, 2024

Subset-specific mitochondrial stress and DNA damage shape T cell responses to fever and inflammation.

Darren R Heintzman, Rachael C Sinard, Emilie L Fisher

|Jun 26, 2024

A Phase II Trial of the WEE1 Inhibitor Adavosertib in SETD2-Altered Advanced Solid Tumor Malignancies (NCI 10170).

Edward Maldonado, W Kimryn Rathmell, Geoffrey I Shapiro

|May 10, 2024

Clinical Trials-Real-World Data to Build a Future for Our Patients.

Catherine C Fahey, W Kimryn Rathmell

Pageof 5

Frequent Collaborators

Jeffrey C Rathmell

Frank M Mason

Emily N Arner

John T Wilson

Durga Nand Tripathi

Sung Yun Jung

Cheryl Lyn Walker

Eric Jonasch

Ruhee Dere

Rahul K Jangid

Frequent Collaborators

Jeffrey C Rathmell

Frank M Mason

Emily N Arner

John T Wilson